Digital Design Accelerator Project to Connect Active Material Design to Product Performance
Perceptive Engineering is pleased to announce our participation in the ‘Digital Design Accelerator’ project (D-DAP). The Digital Design Accelerator is a two-year collaborative project between pharmaceutical companies, solution providers and academia. The project is led by AstraZeneca and is co-funded by the UK’s innovation agency, Innovate UK
This project will apply Industrial Digital Technologies (IDTs) at the interface between the chemically synthesised active pharmaceutical ingredient (API) and the formulated drug product; These technologies may have the potential to transform development methodology and broaden understanding of process parameters on product and process performance, potentially helping to reduce development time, improve robustness and enable continuous improvement through more effective change programmes.
The Digital Design Accelerator project brings together key organisations from across the UK pharmaceutical industry:
Read more about APC for pharma applications or contact Perceptive
Throughout development to manufacturing, data is key to enable rapid response to market demand. The knowledge to enable intelligent decisions and the wisdom to optimise the complete product lifecycle is now at your fingertips. The latest release of PerceptiveAPC v8.0 delivers the next
PD2M May 18-20 2021 Virtual This is the place to explore what pharmaceutical manufacturing will look like in 2030, sharing discussions on new ways to develop medicines. How will Industry 4.0 enable us to respond to market demand, delivering flexible, modular manufacturing and bringing
18-19 May 2021 Virtual Perceptive Engineering - an Applied Materials company - is looking forward to participating in the Bionow Pharma Manufacturing Conference 2021. We will be joining AstraZeneca and Bristol Meyers Squibb in session 2, discussing the ‘Digitisation of Pharma
© Perceptive Engineering Ltd 2022